{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:09:01Z","timestamp":1759536541408,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1053\/j.ajkd.2010.06.031","type":"journal-article","created":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T07:22:32Z","timestamp":1295421752000},"page":"352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Omega-3 Polyunsaturated Fatty Acids and Clinical Trials"],"prefix":"10.1053","volume":"57","author":[{"given":"My","family":"Svensson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaj Anker","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeppe Hagstrup","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1053\/j.ajkd.2010.06.031_bib1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2010.03.009","article-title":"Omega-3 polyunsaturated fatty acids in the treatment of kidney disease","volume":"56","author":"Fassett","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2010.06.031_bib2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2215\/CJN.00630206","article-title":"N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial","volume":"1","author":"Svensson","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2010.06.031_bib3","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1097\/01.ASN.0000019641.41496.1E","article-title":"Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study","volume":"13","author":"Longenecker","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2010.06.031_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5414\/CNP57327","article-title":"Cardiovascular disease risk factors in chronic renal insufficiency","volume":"57","author":"Sarnak","year":"2002","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.06.031_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1053\/j.ajkd.2010.06.031_bib6","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1053\/j.ajkd.2010.06.031_bib7","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1093\/ndt\/gfn180","article-title":"The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study","volume":"23","author":"Svensson","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2010.06.031_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.ajkd.2004.03.024","article-title":"The effect of n-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF","volume":"44","author":"Svensson","year":"2004","journal-title":"Am J Kidney Dis"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638610016756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638610016756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:56:14Z","timestamp":1759456574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638610016756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0272638610016756"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2010.06.031","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omega-3 Polyunsaturated Fatty Acids and Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2010.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2010.03.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}